CR:DOI:c605aab953141c2376f3b8840f0d6d24
From IDWiki
{{#scite:
|reference=pawar2019ri
|type=article-journal
|title=Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
|author=Ajinkya Pawar;Rishi J Desai;Daniel H Solomon;Adrian J Santiago Ortiz;Sara Gale;Min Bao;Khaled Sarsour;Sebastian Schneeweiss;Seoyoung C Kim|+sep=;
|journal=Annals of the Rheumatic Diseases
|publisher=BMJ
|year=2019
|volume=78
|issue=4
|pages=456-464
|doi=10.1136/annrheumdis-2018-214367
|subject=Immunology;General Biochemistry, Genetics and Molecular Biology;Immunology and Allergy;Rheumatology|+sep=;
|issn=0003-4967;1468-2060|+sep=;
|retrieved-from=https://dx.doi.org/
|retrieved-on=2021-02-25
}}
